Related Experiment Video
Updated: Feb 18, 2026
The Pilocarpine Model of Temporal Lobe Epilepsy and EEG Monitoring Using Radiotelemetry System in Mice
Published on: February 27, 2018
Mycophenolate mofetil prevents the delayed T cell response after pilocarpine-induced status epilepticus in mice
Anne-Marie Neumann1,2, Julia Abele1,2, Timo Kirschstein2
1Institute of Immunology, University of Rostock, Rostock, Germany.
Insights
The immune system plays a role in epilepsy. This study reveals a biphasic immune response in the mouse hippocampus after status epilepticus (SE), with T-cells emerging later and being sensitive to early immunomodulation.
Area of Science:
- Neuroimmunology
- Epilepsy Pathophysiology
- Immune Response Kinetics
Background:
- Growing evidence links the immune system to epilepsy development.
- Understanding the immune response post-seizure is crucial for therapeutic strategies.
Purpose of the Study:
- To characterize the temporal immune cell changes in the hippocampus after pilocarpine-induced status epilepticus (SE) in mice.
- To investigate the potential for immunomodulatory intervention in mitigating post-SE immune responses.
Main Methods:
- Pilocarpine-induced SE in C57BL/6 mice.
- Hippocampal analysis using flow cytometry, qRT-PCR, and immunohistochemistry at multiple time points (days 1-4, 14, 28).
- Timm staining to confirm mossy fiber sprouting (epileptogenesis).
Main Results:
- A biphasic immune response was observed: initial macrophage influx followed by a delayed T-lymphocyte increase around day 28.
- The delayed T-cell response showed an elevated CD8/CD4 ratio, suggesting a cytotoxic T-cell mediated response.
- Early administration of mycophenolate mofetil (days 0-3) successfully prevented the delayed T-cell response.
Conclusions:
- Epilepsy pathophysiology involves an orchestrated immunological sequela.
- Delayed T-cell responses post-SE are a targetable mechanism.
- Early immunomodulatory interventions can effectively suppress detrimental post-SE immune cell kinetics.
Abstract:
Growing clinical and laboratory evidence corroborates a role for the immune system in the pathophysiology of epilepsy. In order to delineate the immune response following pilocarpine-induced status epilepticus (SE) in the mouse, we monitored the kinetics of leukocyte presence in the hippocampus over the period of four weeks. SE was induced following a ramping protocol of pilocarpine injection into 4-5 weeks old C57BL/6 mice. Brains were removed at days 1-4, 14 or 28 after SE, and the hippocampi were analyzed via flow cytometry, via quantitative reverse transcriptase PCR (qRT-PCR) and via immunohistochemistry. Epileptogenesis was confirmed by Timm staining of mossy fiber sprouting in the inner molecular layer of the dentate gyrus. The flow cytometry data revealed a biphasic immune response following pilocarpine-induced SE with a transient increase in activated CD11b+ and F4/80+ macrophages within the first four days replaced by an increase in CD3+ T-lymphocytes around day 28. This delayed T cell response was confirmed via qRT-PCR and via immunohistochemistry. In addition, qRT-PCR data could show that the delayed T cell response was associated with an increased CD8/CD4 ratio indicating a cytotoxic T cell response after SE. Intriguingly, early intervention with mycophenolate mofetil administration on days 0-3 after SE prevented this delayed T cell response. These results show an orchestrated immunological sequela and provide evidence that the delayed T cell response is sensitive to early immunomodulatory intervention.
